There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Can an Irish analytics company and its CEO bring pharma closer to 21st-century practice?

Innopharma Bets on Manufacturing 4.0

The company aims to add the additional analytical services in the European Union throughout 2018.

AMRI to Expand Container Closure Integrity Testing Services into EU

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

Novo Nordisk Publishes New Study on Bioproduction of Chemicals

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification. 

ADC Bio to Develop New Bioconjugation Process

A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research. 

Charles River Laboratories Acquires MPI Research

Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.

J&J and Theravance in $1-Billion Deal for Inflammatory Bowel Disease

The company announced the winner of its 2018 Young Chemist Award.

Metrohm USA Announces 6th Annual Young Chemist Award Winner

F. Andreas Toba is Vice President, Intact Pharma Operations, MedInstill Development.

David A. Miller is Manager, Device Performance Engineering, MedInstill Development. 

Bryan R. Campbell is a Doctor of Osteopathic Medicine at Touro University Nevada.

Debashis Sahoo is Executive Vice-President, Regulators & Key Customers, MedInstill Development.

Daniel Py is chairman and CEO, MedInstill Development.

James P. Agalloco is the president of Agalloco & Associates, P.O. Box 899, Belle Mead, NJ 08502, tel. 908.874.7558, jagalloco@aol.com. He is also a member of Pharmaceutical Technology’s editorial advisory board.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

Establishing Correlation Between Aerosol and Surface Microbial Populations

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

New technologies, such as NIR and Raman, enable online measurements of blending and content uniformity in the production of solid dosage forms.

Analyzing Content Uniformity

Fabia Gozzo, PhD, is CEO of Excelsus Structural Solutions, www.excelsusSS.com. With more than 25 years of experience at synchrotron facilities, she has constructed and developed a state-of-the-art powder diffractometer at the Swiss Light Source before founding Excelsus Structural Solutions, a spin-off company that provides synchrotron radiation based analytical services to the pharmaceutical and chemical industry.

X-ray powder diffraction exploits the interaction between x-rays and matter to study the structural and microstructural properties of materials. 

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes